40 related articles for article (PubMed ID: 11338487)
1. Coexpression of c-Myc and p53 as a marker of survival time.
Vollmer RT
Am J Clin Pathol; 2000 Dec; 114(6):983-5. PubMed ID: 11338487
[No Abstract] [Full Text] [Related]
2. Expression of c-Myc and p53 correlates with clinical outcome in diffuse large B-cell lymphomas.
Chang CC; Liu YC; Cleveland RP; Perkins SL
Am J Clin Pathol; 2000 Apr; 113(4):512-8. PubMed ID: 10761452
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of bcl-2, bax, and p53 expression in diffuse large B-cell lymphoma.
Sohn SK; Jung JT; Kim DH; Kim JG; Kwak EK; Park Ti; Shin DG; Sohn KR; Lee KB
Am J Hematol; 2003 Jun; 73(2):101-7. PubMed ID: 12749011
[TBL] [Abstract][Full Text] [Related]
4. [Clinical Significance of P53, C-MYC and BCL-6 Abnormality in Patients with Diffuse Large B Cell Lymphoma].
Chai CG; Zhang JJ; Li N; Cao L; Zhang SY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Feb; 24(1):89-93. PubMed ID: 26913400
[TBL] [Abstract][Full Text] [Related]
5. A non-transgenic mouse model for B-cell lymphoma: in vivo infection of p53-null bone marrow progenitors by a Myc retrovirus is sufficient for tumorigenesis.
Yu D; Thomas-Tikhonenko A
Oncogene; 2002 Mar; 21(12):1922-7. PubMed ID: 11896625
[TBL] [Abstract][Full Text] [Related]
6. MYC translocation and an increased copy number predict poor prognosis in adult diffuse large B-cell lymphoma (DLBCL), especially in germinal centre-like B cell (GCB) type.
Yoon SO; Jeon YK; Paik JH; Kim WY; Kim YA; Kim JE; Kim CW
Histopathology; 2008 Aug; 53(2):205-17. PubMed ID: 18752503
[TBL] [Abstract][Full Text] [Related]
7. Gene-hypermutated isoforms of MYC protein: Tumour-suppressor P-53 protective-initiation of apoptosis that normally prevents Burkitt's lymphoma tumorigenesis can be enhanced.
Wiseman A
Med Hypotheses; 2006; 66(5):1046-7. PubMed ID: 16413684
[No Abstract] [Full Text] [Related]
8. E2F activity is essential for survival of Myc-overexpressing human cancer cells.
Santoni-Rugiu E; Duro D; Farkas T; Mathiasen IS; Jäättelä M; Bartek J; Lukas J
Oncogene; 2002 Sep; 21(42):6498-509. PubMed ID: 12226753
[TBL] [Abstract][Full Text] [Related]
9. [Immunohistochemical study of the predictive value of oncoproteins p53, HER-2 and c-myc during radiotherapy for squamous cell carcinoma of the cervix].
Gasparian NA; Pozharisskiĭ KM; Zharinov GM; Vinokurov VL; Kuznetsova ME; Neklasova NIu
Vopr Onkol; 2007; 53(4):439-44. PubMed ID: 17969407
[TBL] [Abstract][Full Text] [Related]
10. Long term follow-up of c-myc, p53 and proliferation measurements in malignant melanoma.
Ross DA; Laing JH; Sanders R; Wilson GD
Eur J Surg Oncol; 2006 Feb; 32(1):80-4. PubMed ID: 16256294
[TBL] [Abstract][Full Text] [Related]
11. Comparative immunohistochemical analysis of pediatric Burkitt lymphoma and diffuse large B-cell lymphoma.
Frost M; Newell J; Lones MA; Tripp SR; Cairo MS; Perkins SL
Am J Clin Pathol; 2004 Mar; 121(3):384-92. PubMed ID: 15023043
[TBL] [Abstract][Full Text] [Related]
12. Primary lymphoma of the liver -- morphological and clinical analysis of 6 cases. Success of aggressive treatment.
Ziarkiewicz-Wroblewska B; Gornicka B; Suleiman W; Wroblewski T; Morton M; Wilczynski GM; Heleniak H; Skwarek A; Koperski L; Dudek K; Krawczyk M; Jedrzejczak WW; Dwilewicz-Trojaczek J; Wasiutynski A
Neoplasma; 2005; 52(3):267-72. PubMed ID: 15875091
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of p53 and matrix metalloproteinase-9 expression in follicular lymphoma.
Pennanen H; Kuittinen O; Soini Y; Turpeenniemi-Hujanen T
Eur J Haematol; 2008 Oct; 81(4):289-97. PubMed ID: 18616513
[TBL] [Abstract][Full Text] [Related]
14. Myc and E2F1 induce p53 through p14ARF-independent mechanisms in human fibroblasts.
Lindström MS; Wiman KG
Oncogene; 2003 Aug; 22(32):4993-5005. PubMed ID: 12902982
[TBL] [Abstract][Full Text] [Related]
15. Myc suppression of the p21(Cip1) Cdk inhibitor influences the outcome of the p53 response to DNA damage.
Seoane J; Le HV; Massagué J
Nature; 2002 Oct; 419(6908):729-34. PubMed ID: 12384701
[TBL] [Abstract][Full Text] [Related]
16. Expression and prognostic implications of cell cycle regulatory molecules, p16, p21, p27, p14 and p53 in germinal centre and non-germinal centre B-like diffuse large B-cell lymphomas.
Paik JH; Jeon YK; Park SS; Kim YA; Kim JE; Huh J; Lee SS; Kim WH; Kim CW
Histopathology; 2005 Sep; 47(3):281-91. PubMed ID: 16115229
[TBL] [Abstract][Full Text] [Related]
17. Targeted delivery of oncogene-selective antisense oligonucleotides in neuroectodermal tumors: therapeutic implications.
Pastorino F; Brignole C; Marimpietri D; Di Paolo D; Zancolli M; Pagnan G; Ponzoni M
Ann N Y Acad Sci; 2004 Dec; 1028():90-103. PubMed ID: 15650235
[TBL] [Abstract][Full Text] [Related]
18. Assessment of biological prognostic factors provides clinically relevant information in patients with diffuse large B-cell lymphoma--a Nordic Lymphoma Group study.
Jerkeman M; Anderson H; Dictor M; Kvaløy S; Akerman M; Cavallin-Ståhl E;
Ann Hematol; 2004 Jul; 83(7):414-9. PubMed ID: 15085385
[TBL] [Abstract][Full Text] [Related]
19. pRb, Myc and p53 are critically involved in SV40 large T antigen repression of PDGF beta-receptor transcription.
Uramoto H; Hackzell A; Wetterskog D; Ballági A; Izumi H; Funa K
J Cell Sci; 2004 Aug; 117(Pt 17):3855-65. PubMed ID: 15265983
[TBL] [Abstract][Full Text] [Related]
20. Acute and chronic effects of alcohol exposure on skeletal muscle c-myc, p53, and Bcl-2 mRNA expression.
Nakahara T; Hashimoto K; Hirano M; Koll M; Martin CR; Preedy VR
Am J Physiol Endocrinol Metab; 2003 Dec; 285(6):E1273-81. PubMed ID: 12876071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]